# Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Study · id `cardio:ct-nct07599982` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07599982](<https://clinicaltrials.gov/study/NCT07599982>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07599982

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 102 participants.

## Technical summary

Registry record NCT07599982. Allocation not applicable; no masking; primary purpose treatment. Start 2026-05-25 (actual); primary completion 2027-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 102 participants (planned count; ClinicalTrials.gov record NCT07599982, source copy `cardio:ctgov-nct07599982-2026-08-28`, retrieved 2026-10-26)
- Started: 2026-05-25 (actual) (ClinicalTrials.gov record NCT07599982, source copy `cardio:ctgov-nct07599982-2026-08-28`, retrieved 2026-10-26)
- Primary completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT07599982, source copy `cardio:ctgov-nct07599982-2026-08-28`, retrieved 2026-10-26)
- Completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT07599982, source copy `cardio:ctgov-nct07599982-2026-08-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07599982, source copy `cardio:ctgov-nct07599982-2026-08-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07599982-2026-08-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Acronym: MODIUS
- Condition: Type 1 Diabetes (T1D)
- Condition: Type 2 Diabetes (T2D)
- Intervention (Device): MODI Algorithm
- Lead sponsor: DreaMed Diabetes
- Lead sponsor class: INDUSTRY
- Collaborator: Jaeb Center for Health Research
- Collaborator class: OTHER
- Collaborator: Abbott Diabetes Care
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Jaeb Center for Health Research (`cardio:org-jaeb-center-for-health-research`)
- Registry lists this organization as a collaborator: Abbott Diabetes Care (`cardio:org-abbott-diabetes-care`)

## Provenance

Content hash: 5c549c946daed353ecb82252afa51a00e69c86411ea03b1e290cfe75dfa1c39e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
